Zynerba Pharmaceuticals Inc Shares Approach 52-Week Low - Market Mover
The shares closed 1.9% above its 52-week low of $2.58, with trading volume higher than its 30 day average
Jan 13, 2022 by Kwhen Finance Editors
Zynerba Pharmaceuticals Inc (ZYNE) shares closed today at 1.9% above its 52 week low of $2.58, giving the company a market cap of $112M. The stock is currently down 5.6% year-to-date, down 21.2% over the past 12 months, and down 85.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%.
Trading Activity
- Trading volume this week was 47.9% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
Zynerba Pharmaceuticals Inc | -3.3 | -5.6 | -21.2 | -69.7 | 5.8 |
Dow Jones Industrial Average | 0.1 | -0.2 | 18.9 | -1.6 | 23.8 |
S&P 500 Index | 0.3 | -1.1 | 25.7 | -1.7 | 29.8 |
Health Care | -0.3 | -3.5 | 14.4 | -4.5 | 22.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -677.8%
- The company's stock price performance over the past 12 months lags the peer average by 40.0%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
Zynerba Pharmaceuticals Inc | ZYNE | 0 | -5.6 | -21.2 | -69.7 | 5.8 |
Peer Avg | N/A | 0 | 1.0 | -15.1 | -15.8 | 21.9 |
Otonomy Inc | OTIC | 0 | 3.8 | -60.4 | -63.3 | 87.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: